Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D07TTI
|
|||
| Former ID |
DIB000360
|
|||
| Drug Name |
AZD-8309
|
|||
| Indication | Chronic obstructive pulmonary disease [ICD-11: CA22; ICD-10: J44, J44.9] | Discontinued in Phase 1 | [1] | |
| Rheumatoid arthritis [ICD-11: FA20] | Discontinued in Phase 1 | [1] | ||
| Company |
AstraZeneca plc
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Chemokine receptor (CHR) | Target Info | Modulator | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800017125) | |||
| REF 2 | CXCR2: From Bench to Bedside. Front Immunol. 2012; 3: 263. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.